Despite Rising Rates Of Depression, It's Doubtful We'll See New Drugs
Pharmaceutical companies aren't investing in antidepressants research because the risks are too high.
despite rise rate depression doubtful new dr USA pharmaceutical company invest antidepressant research risk high